Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • TTX2026
    • TTX 2026 (28-29 Nov)
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

1.89
+0.06003.28%
Post-market: 1.890.00000.00%19:30 EDT
Volume:91.63K
Turnover:172.02K
Market Cap:52.45M
PE:-2.72
High:1.91
Open:1.84
Low:1.84
Close:1.83
52wk High:2.60
52wk Low:1.09
Shares:27.75M
Float Shares:23.19M
Volume Ratio:0.34
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6937
EPS(LYR):-1.8600
ROE:-74.82%
ROA:-39.12%
PB:2.58
PE(LYR):-1.02

Loading ...

OverviewCompanyNewsFilings

INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update

GlobeNewswire
·
May 08

INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
May 06

INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases

GlobeNewswire
·
May 06

INmune Bio to report Q1 results, host conference call and webcast May 7

Reuters
·
Apr 30

INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th

GlobeNewswire
·
Apr 30

INmune Bio announces new preclinical data for INB03

TIPRANKS
·
Apr 16

INmune Bio reports AACR preclinical data for INB03 in HER2-positive breast cancer models

Reuters
·
Apr 16

INmune Bio Inc. Announces New Preclinical Data at Aacr 2026 Demonstrating Inb03 (Xpro1595) Overcomes Resistance and Reduces Metastases in Her2-Positive Breast Cancer Models

THOMSON REUTERS
·
Apr 16

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Post-Mkt
Financial Report Announcement
May 07, 2026 Post-Mkt
Financial Report Announcement
Mar 30, 2026 Post-Mkt
Financial Report Announcement
Oct 30, 2025 Post-Mkt
Financial Report Announcement
Aug 07, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.72
Current
-4.32
Sector Average
75.26%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.72
Maximum
-0.64
+1 STD
-1.56
Minimum
-18.61
-1 STD
-7.08
Average
-4.32

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.